(BF-B) Brown-Forman - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US1156372096

Spirits, Whiskey, Vodka, Tequila, Rum

Distillers & Vintners
Market Cap in USD: 12,206m

IPO / Inception: 1984-09-07
12m vs SPY: -32.2%

EPS (Earnings per Share)

EPS CAGR: -3.63%
EPS Trend: 5.0%

Last SUE: 0.00
Qual. Beats: 0

Revenue

Rev. CAGR: -0.03%
Rev. Trend: -38.3%

Last SUE: 0.42
Qual. Beats: 0

Dividends

Dividend Yield	2.99%
Yield on Cost 5y	1.35%
Yield CAGR 5y	-14.78%
Payout Consistency	88.7%
Payout Ratio	53.3%

Risk via 5d forecast
Volatility	31.7%
Value at Risk 5%th	49.6%
Relative Tail Risk	-4.70%

Reward TTM
Sharpe Ratio	-0.46
Alpha	-31.61
CAGR/Max DD	-0.39

Character TTM
Hurst Exponent	0.526
Beta	0.550
Beta Downside	0.328

Drawdowns 3y
Max DD	62.30%
Mean DD	32.49%
Median DD	34.07%

Description: BF-B Brown-Forman January 02, 2026

Brown-Forman Corp. (NYSE: BF-B) is a global producer and marketer of distilled spirits and wines, operating a portfolio that includes flagship brands such as Jack Daniel’s, Woodford Reserve, Old Forester, and Herradura, as well as a range of premium whiskies, vodkas, gins, and ready-to-drink cocktails. The firm also monetizes secondary assets through used-barrel sales, bulk whiskey and wine transactions, and contract bottling services, serving retail, wholesale, and governmental channels across North America, Europe, Asia-Pacific, and Latin America.

Key performance indicators from FY 2024 show net sales of roughly $4.6 billion, an operating margin of 28 %, and a free-cash-flow conversion of about 70 % of earnings, reflecting strong pricing power in the premium-spirits segment. The business’s exposure to discretionary consumer spending makes it sensitive to macro-economic variables such as U.S. consumer confidence and real disposable income, while the ongoing “premiumization” trend-where consumers shift toward higher-priced, higher-quality spirits-has been a primary growth driver. Additionally, the company’s relatively low leverage (debt-to-equity ~0.4×) provides flexibility to fund acquisitions or share-repurchase programs.

For a deeper quantitative assessment, you may find ValueRay’s platform useful for comparing BF-B’s valuation and risk metrics against its peers.

Piotroski VR‑10 (Strict, 0-10) 5.5

Net Income (810.0m TTM) > 0 and > 6% of Revenue (6% = 233.3m TTM)

FCFTA 0.07 (>2.0%) and ΔFCFTA 1.92pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue 71.87% (prev 64.80%; Δ 7.07pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.09 (>3.0%) and CFO 761.0m <= Net Income 810.0m (YES >=105%, WARN >=100%)

Net Debt (2.33b) to EBITDA (1.19b) ratio: 1.96 <= 3.0 (WARN <= 3.5)

Current Ratio 2.97 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (472.6m) change vs 12m ago -0.10% (target <= -2.0% for YES)

Gross Margin 59.12% (prev 59.21%; Δ -0.09pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 46.99% (prev 48.96%; Δ -1.97pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio 7.72 (EBITDA TTM 1.19b / Interest Expense TTM 106.0m) >= 6 (WARN >= 3)

Altman Z'' 6.05

(A) 0.34 = (Total Current Assets 4.21b - Total Current Liabilities 1.42b) / Total Assets 8.22b

(B) 0.59 = Retained Earnings (Balance) 4.89b / Total Assets 8.22b

(D) 1.15 = Book Value of Equity 4.72b / Total Liabilities 4.09b

Total Rating: 6.05 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 61.87

1. Piotroski 5.50pt

2. FCF Yield 4.20%

3. FCF Margin 15.69%

4. Debt/Equity 0.64

5. Debt/Ebitda 1.96

6. ROIC - WACC (= 3.12)%

7. RoE 20.33%

8. Rev. Trend -38.28%

9. EPS Trend 5.02%

What is the price of BF-B shares?

As of January 16, 2026, the stock is trading at USD 27.20 with a total of 9,235,988 shares traded.
Over the past week, the price has changed by +7.30%, over one month by -10.44%, over three months by -0.42% and over the past year by -18.61%.

Is BF-B a buy, sell or hold?

Brown-Forman has received a consensus analysts rating of 3.00. Therefor, it is recommend to hold BF-B.

Strong Buy: 2
Buy: 3
Hold: 10
Sell: 3
Strong Sell: 2

What are the forecasts/targets for the BF-B price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	31	13.8%
Analysts Target Price	31	13.8%
ValueRay Target Price	22.5	-17.2%

BF-B Fundamental Data Overview January 14, 2026

P/E Trailing = 15.4094
P/E Forward = 15.9744
P/S = 3.1385
P/B = 2.9525
P/EG = 4.7529
Revenue TTM = 3.89b USD
EBIT TTM = 818.0m USD
EBITDA TTM = 1.19b USD
Long Term Debt = 2.07b USD (from longTermDebt, last quarter)
Short Term Debt = 575.0m USD (from shortTermDebt, last quarter)
Debt = 2.65b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.33b USD (from netDebt column, last quarter)
Enterprise Value = 14.53b USD (12.21b + Debt 2.65b - CCE 319.0m)
Interest Coverage Ratio = 7.72 (Ebit TTM 818.0m / Interest Expense TTM 106.0m)
EV/FCF = 23.83x (Enterprise Value 14.53b / FCF TTM 610.0m)
FCF Yield = 4.20% (FCF TTM 610.0m / Enterprise Value 14.53b)
FCF Margin = 15.69% (FCF TTM 610.0m / Revenue TTM 3.89b)
Net Margin = 20.83% (Net Income TTM 810.0m / Revenue TTM 3.89b)
Gross Margin = 59.12% ((Revenue TTM 3.89b - Cost of Revenue TTM 1.59b) / Revenue TTM)
Gross Margin QoQ = 59.36% (prev 59.74%)
Tobins Q-Ratio = 1.77 (Enterprise Value 14.53b / Total Assets 8.22b)
Interest Expense / Debt = 0.87% (Interest Expense 23.0m / Debt 2.65b)
Taxrate = 19.71% (55.0m / 279.0m)
NOPAT = 656.7m (EBIT 818.0m * (1 - 19.71%))
Current Ratio = 2.97 (Total Current Assets 4.21b / Total Current Liabilities 1.42b)
Debt / Equity = 0.64 (Debt 2.65b / totalStockholderEquity, last quarter 4.13b)
Debt / EBITDA = 1.96 (Net Debt 2.33b / EBITDA 1.19b)
Debt / FCF = 3.82 (Net Debt 2.33b / FCF TTM 610.0m)
Total Stockholder Equity = 3.98b (last 4 quarters mean from totalStockholderEquity)
RoA = 9.79% (Net Income 810.0m / Total Assets 8.22b)
RoE = 20.33% (Net Income TTM 810.0m / Total Stockholder Equity 3.98b)
RoCE = 13.51% (EBIT 818.0m / Capital Employed (Equity 3.98b + L.T.Debt 2.07b))
RoIC = 9.77% (NOPAT 656.7m / Invested Capital 6.72b)
WACC = 6.65% (E(12.21b)/V(14.85b) * Re(7.94%) + D(2.65b)/V(14.85b) * Rd(0.87%) * (1-Tc(0.20)))
Discount Rate = 7.94% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -0.78%
[DCF Debug] Terminal Value 83.06% ; FCFF base≈549.2m ; Y1≈539.3m ; Y5≈550.5m
Fair Price DCF = 36.85 (EV 13.18b - Net Debt 2.33b = Equity 10.86b / Shares 294.6m; r=6.65% [WACC]; 5y FCF grow -2.73% → 2.90% )
EPS Correlation: 5.02 | EPS CAGR: -3.63% | SUE: 0.0 | # QB: 0
Revenue Correlation: -38.28 | Revenue CAGR: -0.03% | SUE: 0.42 | # QB: 0
EPS current Year (2026-04-30): EPS=1.65 | Chg30d=+0.010 | Revisions Net=+0 | Growth EPS=-10.5% | Growth Revenue=-3.3%
EPS next Year (2027-04-30): EPS=1.74 | Chg30d=-0.000 | Revisions Net=-1 | Growth EPS=+5.5% | Growth Revenue=+1.7%

Additional Sources for BF-B Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle